Multiple Assemblies exist for SMTL entry 4bn5
Structure of human SIRT3 in complex with SRT1720 inhibitor; X-RAY DIFFRACTION 3.25 Å

	SMTL ID 4bn5.1 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.2 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.3 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; GLYCEROL; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.4 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; GLYCEROL; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.5 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.6 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.7 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.8 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.9 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.10 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.11 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; GLYCEROL; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer
	SMTL ID 4bn5.12 Ligands CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE; GLYCEROL; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide; ZINC ION Polypeptides NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL Oligo-state monomer